Sort
8,912 grants matching “sars cov 2”
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
$789,887Susan C. Baker · Loyola University Chicago · R01 · FY2021 · AI
Impact of Care Delivery and Therapeutic Changes on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$789,438John Hsu · Massachusetts General Hospital · U01 · FY2025 · AG
Isolation of bioactive proteins from natural product extracts
$789,298Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Micro Analytical Immunochemistry
$789,255Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2023 · EB
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES
$789,214Rick Stevens · University Of Chicago · N01 · FY2023 · AI
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
$789,208Pia S Pannaraj · University Of California, San Diego · R01 · FY2024 · AI
SARS-CoV-2 whole genome sequencing from large-scale campus testing and state-wide communities in NH
$789,189Rick H Cote · University Of New Hampshire · P20 · FY2022 · GM
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States
$788,893Becky Lynn Genberg · Johns Hopkins University · R01 · FY2022 · DA
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions
$788,805Frederick R Haselton · Vanderbilt University · R01 · FY2021 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$788,776Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2024 · AI
Anticipating and rapidly responding to respiratory virus outbreaks with continuous air sampling in K-12 schools
$788,684David H Oconnor · University Of Wisconsin-Madison · R01 · FY2023 · AI
Novel Point-of-Care Device for Urinary Hepcidin to Detect Iron Deficiency in Children and Adolescents
$788,664Vaughn E Ostland · Intrinsic Lifesciences, Llc · R44 · FY2023 · DK
Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health Study- (WHA REACH ) Study
$788,653Joan Packenham · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
COVID-19, Inflammation and HPA axis activity, and Risk for Psychopathology in Youth
$788,640Nadine M. Melhem · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · MH
Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2
$788,453Samarjit Das · Johns Hopkins University · U18 · FY2021 · TR
Immune response to COVID-19 vaccine in HIV infected men and women
$788,164Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Determination of mucosal immune responses to, and infection of the gastrointestinal tract by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
$787,826Saurabh Mehandru · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
$787,601Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
National Alzheimer's Coordinating Center
$786,494Walter A Kukull · University Of Washington · U24 · FY2021 · AG
Identification of the Initial Targets of Transmission
$786,043Thomas Hope · Northwestern University At Chicago · R37 · FY2020 · AI
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites
$785,945Joshua Tisdell Schiffer · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Core B - Technology Core
$785,873Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
COVID-19 - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings
$785,776Saad B. Omer · Yale University · R01 · FY2022 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$785,611Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2025 · AI
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
$785,479Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI